| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLNO | Common Stock | Sale | -$129K | -2.83K | -2.66% | $45.48 | 103K | Aug 5, 2024 | Direct | F1, F2, F3 |
| transaction | SLNO | Common Stock | Sale | -$101K | -2.19K | -2.12% | $46.14 | 101K | Aug 5, 2024 | Direct | F1, F3, F4 |
| transaction | SLNO | Common Stock | Sale | -$25.5K | -585 | -0.58% | $43.64 | 101K | Aug 6, 2024 | Direct | F1, F3, F5 |
| transaction | SLNO | Common Stock | Sale | -$89.4K | -1.98K | -1.96% | $45.25 | 98.7K | Aug 6, 2024 | Direct | F1, F3, F6 |
| transaction | SLNO | Common Stock | Sale | -$156K | -3.4K | -3.44% | $45.89 | 95.3K | Aug 6, 2024 | Direct | F1, F3, F7 |
| Id | Content |
|---|---|
| F1 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
| F2 | This transaction was executed in multiple trades at prices ranging from $44.87 to $45.86. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F3 | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
| F4 | This transaction was executed in multiple trades at prices ranging from $45.87 to $46.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F5 | This transaction was executed in multiple trades at prices ranging from $43.245 to $44.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F6 | This transaction was executed in multiple trades at prices ranging from $44.66 to $45.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F7 | This transaction was executed in multiple trades at prices ranging from $45.66 to $46.40. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
Officer title: Senior Vice President, Clinical Operations